Tempus AI因罕见癌症研究合作而股价上涨

路透中文06-25 22:01
BUZZ-<a href="https://laohu8.com/S/TEM">Tempus AI</a>因罕见癌症研究合作而股价上涨

6月25日 - ** 人工智能驱动的精准医疗公司Tempus AI TEM.O 股价上涨3.7%,至53.85美元

** 该公司宣布与“血管肉瘤意识组织”(Angiosarcoma Awareness)建立研究合作关系,该组织是一家由患者主导的慈善机构,致力于支持患者并为血管肉瘤研究提供资金

** 血管肉瘤是一种起源于血管内皮细胞的罕见且侵袭性强的癌症;该公司表示,美国每年约有1,000人被确诊

** 公司表示,此次合作将利用约600份经过去识别化的血管肉瘤病例记录,其中包含DNA和RNA测序数据,以及可获取的临床信息

** 该公司表示,该数据集是已知规模最大的血管肉瘤分子数据集之一,有望帮助发现疾病模式并探索潜在的治疗机会

** 包括本次交易在内,TEM今年以来累计下跌7.6%

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment